-
公开(公告)号:US11957894B2
公开(公告)日:2024-04-16
申请号:US16947947
申请日:2020-08-25
Applicant: Medtronic, Inc.
Inventor: Anthony M. Chasensky , Bernard Q. Li , Brad C. Tischendorf , Chris J. Paidosh , Christian S. Nielsen , Craig L. Schmidt , David A. Dinsmoor , Duane L. Bourget , Eric H. Bonde , Erik R. Scott , Forrest C M Pape , Gabriela C. Molnar , Gordon O. Munns , Joel A. Anderson , John E. Kast , Joseph J. Viavattine , Markus W. Reiterer , Michael J. Ebert , Phillip C. Falkner , Prabhakar A. Tamirisa , Randy S. Roles , Reginald D. Robinson , Richard T. Stone , Shawn C. Kelley , Stephen J. Roddy , Thomas P. Miltich , Timothy J. Denison , Todd V. Smith , Xuan K. Wei
CPC classification number: A61N1/02 , A61B17/00234 , A61N1/05 , A61N1/0551 , A61N1/36007 , A61N1/3605 , A61N1/36057 , A61N1/36067 , A61N1/36071 , A61N1/36139 , A61N1/37205 , A61N1/37223 , A61N1/37235 , A61N1/37247 , A61N1/3727 , A61N1/3754 , A61N1/3756 , A61N1/3787 , A61N1/36021 , A61N1/36053 , A61N1/37211 , A61N1/37518 , F04C2270/0421
Abstract: A neuromodulation therapy is delivered via at least one electrode implanted subcutaneously and superficially to a fascia layer superficial to a nerve of a patient. In one example, an implantable medical device is deployed along a superficial surface of a deep fascia tissue layer superficial to a nerve of a patient. Electrical stimulation energy is delivered to the nerve through the deep fascia tissue layer via implantable medical device electrodes.
-
公开(公告)号:US11957893B2
公开(公告)日:2024-04-16
申请号:US16947944
申请日:2020-08-25
Applicant: Medtronic, Inc.
Inventor: Brad C. Tischendorf , John E. Kast , Thomas P. Miltich , Gordon O. Munns , Randy S. Roles , Craig L. Schmidt , Joseph J. Viavattine , Christian S. Nielsen , Prabhakar A. Tamirisa , Anthony M. Chasensky , Markus W. Reiterer , Chris J. Paidosh , Reginald D. Robinson , Bernard Q. Li , Erik R. Scott , Phillip C. Falkner , Xuan K. Wei , Eric H. Bonde , David A. Dinsmoor , Duane L. Bourget , Forrest C M Pape , Gabriela C. Molnar , Joel A. Anderson , Michael J. Ebert , Richard T. Stone , Shawn C. Kelley , Stephen J. Roddy , Timothy J. Denison , Todd V. Smith
CPC classification number: A61N1/02 , A61B17/00234 , A61N1/05 , A61N1/0551 , A61N1/36007 , A61N1/3605 , A61N1/36057 , A61N1/36067 , A61N1/36071 , A61N1/36139 , A61N1/37205 , A61N1/37223 , A61N1/37235 , A61N1/37247 , A61N1/3727 , A61N1/3754 , A61N1/3756 , A61N1/3787 , A61N1/36021 , A61N1/36053 , A61N1/37211 , A61N1/37518 , F04C2270/0421
Abstract: A neuromodulation therapy is delivered via at least one electrode implanted subcutaneously and superficially to a fascia layer superficial to a nerve of a patient. In one example, an implantable medical device is deployed along a superficial surface of a deep fascia tissue layer superficial to a nerve of a patient. Electrical stimulation energy is delivered to the nerve through the deep fascia tissue layer via implantable medical device electrodes.
-
公开(公告)号:US20200376259A1
公开(公告)日:2020-12-03
申请号:US16947953
申请日:2020-08-25
Applicant: Medtronic, Inc.
Inventor: Anthony M. Chasensky , Bernard Q. Li , Brad C. Tischendorf , Chris J. Paidosh , Christian S. Nielsen , Craig L. Schmidt , David A. Dinsmoor , Duane L. Bourget , Eric H. Bonde , Erik R. Scott , Forrest C M Pape , Gabriela C. Molnar , Gordon O. Munns , Joel A. Anderson , John E. Kast , Joseph J. Viavattine , Markus W. Reiterer , Michael J. Ebert , Phillip C. Falkner , Prabhakar A. Tamirisa , Randy S. Roles , Reginald D. Robinson , Richard T. Stone , Shawn C. Kelley , Stephen J. Roddy , Thomas P. Miltich , Timothy J. Denison , Todd V. Smith , Xuan K. Wei
Abstract: A medical device system for delivering a neuromodulation therapy includes a delivery tool for deploying an implantable medical device at a neuromodulation therapy site. The implantable medical device includes a housing, an electronic circuit within the housing, and an electrical lead comprising a lead body extending between a proximal end coupled to the housing and a distal end extending away from the housing and at least one electrode carried by the lead body. The delivery tool includes a first cavity for receiving the housing and a second cavity for receiving the lead. The first cavity and the second cavity are in direct communication for receiving and deploying the housing and the lead coupled to the housing concomitantly as a single unit.
-
公开(公告)号:US11672969B2
公开(公告)日:2023-06-13
申请号:US16947954
申请日:2020-08-25
Applicant: Medtronic, Inc.
Inventor: Anthony M. Chasensky , Bernard Q. Li , Brad C. Tischendorf , Chris J. Paidosh , Christian S. Nielsen , Craig L. Schmidt , David A. Dinsmoor , Duane L. Bourget , Eric H. Bonde , Erik R. Scott , Forrest C M Pape , Gabriela C. Molnar , Gordon O. Munns , Joel A. Anderson , John E. Kast , Joseph J. Viavattine , Markus W. Reiterer , Michael J. Ebert , Phillip C. Falkner , Prabhakar A. Tamirisa , Randy S. Roles , Reginald D. Robinson , Richard T. Stone , Shawn C. Kelley , Stephen J. Roddy , Thomas P. Miltich , Timothy J. Denison , Todd V. Smith , Xuan K. Wei
CPC classification number: A61N1/02 , A61B17/00234 , A61N1/05 , A61N1/0551 , A61N1/3605 , A61N1/36007 , A61N1/36057 , A61N1/36067 , A61N1/36071 , A61N1/36139 , A61N1/3727 , A61N1/3754 , A61N1/3756 , A61N1/3787 , A61N1/37205 , A61N1/37223 , A61N1/37235 , A61N1/37247 , A61N1/36021 , A61N1/36053 , A61N1/37211 , A61N1/37518 , F04C2270/0421
Abstract: A medical device system for delivering a neuromodulation therapy includes a delivery tool for deploying an implantable medical device at a neuromodulation therapy site. The implantable medical device includes a housing, an electronic circuit within the housing, and an electrical lead comprising a lead body extending between a proximal end coupled to the housing and a distal end extending away from the housing and at least one electrode carried by the lead body. The delivery tool includes a first cavity for receiving the housing and a second cavity for receiving the lead. The first cavity and the second cavity are in direct communication for receiving and deploying the housing and the lead coupled to the housing concomitantly as a single unit.
-
公开(公告)号:US20200376255A1
公开(公告)日:2020-12-03
申请号:US16947944
申请日:2020-08-25
Applicant: Medtronic, Inc.
Inventor: Brad C. Tischendorf , John E. Kast , Thomas P. Miltich , Gordon O. Munns , Randy S. Roles , Craig L. Schmidt , Joseph J. Viavattine , Christian S. Nielsen , Prabhakar A. Tamirisa , Anthony M. Chasensky , Markus W. Reiterer , Chris J. Paidosh , Reginald D. Robinson , Bernard Q. Li , Erik R. Scott , Phillip C. Falkner , Xuan K. Wei , Eric H. Bonde , David A. Dinsmoor , Duane L. Bourget , Forrest C M Pape , Gabriela C. Molnar , Joel A. Anderson , Michael J. Ebert , Richard T. Stone , Shawn C. Kelley , Stephen J. Roddy , Timothy J. Denison , Todd V. Smith
Abstract: A neuromodulation therapy is delivered via at least one electrode implanted subcutaneously and superficially to a fascia layer superficial to a nerve of a patient. In one example, an implantable medical device is deployed along a superficial surface of a deep fascia tissue layer superficial to a nerve of a patient. Electrical stimulation energy is delivered to the nerve through the deep fascia tissue layer via implantable medical device electrodes.
-
-
-
-